Quit Smoking With Nicotine Patch and Exercise/Health Education (Females Only)

Efficacy of Brisk Walking as a Smoking Cessation Treatment Adjunct Among Women

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01522274

Acronym

QFH

Enrollment

113

Registered

2012-01-31

Start date

2012-01-31

Completion date

2017-07-31

Last updated

2017-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cigarette Smoking

Brief summary

This research study is for FEMALE cigarette smokers who want to quit smoking. Participants will be provided with brief quit-smoking education at the beginning of the study and will receive the nicotine patch for 10 weeks, free of charge. Participants will be assigned to either an exercise program or a general health education program. The exercise and health education programs will take place over 14 weeks, with follow-up appointments 3, 6, and 12 months after the end of the 14-week program. There is no fee for any part of this study and participants will be compensated for their time.

Detailed description

Participants must complete telephone screening process first. All eligible participants must attend an orientation session when the investigators will explain the study in detail. After this session, interested participants will complete a consent form and the investigators will collect blood pressure, resting heart rate, body mass index (height/weight), and a carbon monoxide sample to confirm eligibility. The investigators will then explain the physician consent process (all eligible and interested participants must obtain consent from a physician or clinic that they have seen in the past year to confirm that it is safe for them to participate).

Interventions

BEHAVIORALModerate intensity exercise

Brisk walking on a treadmill for 56 minutes 3x per week.

BEHAVIORALHealth education

Videos

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 55 Years

Healthy volunteers

Yes

Inclusion criteria

* Current smoker

Exclusion criteria

* Ineligible after telephone screen. * Each participant's personal physician/clinic determines it is unsafe to participate.

Design outcomes

Primary

Measure	Time frame	Description
Smoking Cessation	7-Day Point Prevalence at 3, 6, 9 and 1-year follow-ups	Verified by saliva cotinine

Secondary

Measure	Time frame	Description
Cognitive and Affective Mechanisms of Treatment	Daily assessments completed throughout the day at random and scheduled times from baseline to 3 months	E-diary use will collect daily cognitive and affective data from each participant in order to reveal mechanisms of treatment outcomes.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026